These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10961858)

  • 1. Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
    Blanpain C; Lee B; Tackoen M; Puffer B; Boom A; Libert F; Sharron M; Wittamer V; Vassart G; Doms RW; Parmentier M
    Blood; 2000 Sep; 96(5):1638-45. PubMed ID: 10961858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
    Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
    Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
    Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
    Blanpain C; Lee B; Vakili J; Doranz BJ; Govaerts C; Migeotte I; Sharron M; Dupriez V; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Jul; 274(27):18902-8. PubMed ID: 10383387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
    Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
    J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
    Dong HF; Wigmore K; Carrington MN; Dean M; Turpin JA; Howard OM
    Genes Immun; 2005 Oct; 6(7):609-19. PubMed ID: 16015368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
    Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
    Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
    Staudinger R; Wang X; Bandrés JC
    Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chemokine-mediated block to HIV entry with coreceptor internalization.
    Brandt SM; Mariani R; Holland AU; Hope TJ; Landau NR
    J Biol Chem; 2002 May; 277(19):17291-9. PubMed ID: 11782464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
    Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
    J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY; Togni M; Widmer U
    Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.